EGFR and adenocarcinoma: These authors observed that adenocarcinoma with solid pattern (ADC-S) and nonkeratinizing squamous cell carcinoma (NK-SQCC), which were excluded from the 2015 WHO criteria of LCC, exhibited various gene mutations, including EGFR, KRAS, TP53 and other genes.